Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care

The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

Endocrine Abstracts ◽

10.1530/endoabs.49.ep598 ◽

2017 ◽

Author(s):

M G Bubnova ◽

D M Aronov ◽

Marina Bubnoa ◽

David Aronov

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Diseases ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Essential Phospholipids

135-OR: The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db20-135-or ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 135-OR

Author(s):

ELENI PAPPA ◽

CHRISTINA KOSTARA ◽

CONSTANTINOS TELLIS ◽

ALEXANDROS D. TSELEPIS ◽

ELENI BAIRAKTARI ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Lipoprotein Metabolism ◽

Serum Lipoprotein ◽

Insulin Degludec ◽

Fixed Dose Combination ◽

Fixed Dose ◽

BLOOD PRESSURE LOWERING RESPONSE WITH THE FIXED DOSE COMBINATION PERINDOPRIL/INDAPAMIDE IN THAI PATIENTS WITH TYPE 2 DIABETES AND ADDED RISK FACTORS: PP.5.190

Journal of Hypertension ◽

10.1097/01.hjh.0000378514.03077.46 ◽

2010 ◽

Vol 28 ◽

pp. e105

Author(s):

V Ophascharoensuk ◽

K Phimda

Keyword(s):

Risk Factors ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Blood Pressure Lowering ◽

Pressure Lowering ◽

Sitagliptin and Metformin in Fixed Dose Combination: The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes

Clinical Medicine Reviews in Vascular Health ◽

10.4137/cmrvh.s3372 ◽

2010 ◽

Vol 2 ◽

pp. 201-215

Author(s):

Baptist Gallwitz

Keyword(s):

Type 2 Diabetes ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Therapeutic Impact ◽

Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.13989 ◽

2020 ◽

Vol 22 (6) ◽

pp. 1001-1005

Author(s):

Niki Katsiki ◽

Richard Ofori‐Asenso ◽

Ele Ferrannini ◽

Mohsen Mazidi

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2013.770839 ◽

2013 ◽

Vol 14 (4) ◽

pp. 361-370 ◽

Cited By ~ 12

Author(s):

Yuri Ono ◽

Hiraku Kameda ◽

Kyu Yong Cho

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Review for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"

10.1111/dom.13989/v1/review2 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes

Postgraduate Medicine ◽

10.1080/00325481.2020.1750228 ◽

2020 ◽

Vol 132 (4) ◽

pp. 337-345 ◽

Cited By ~ 1

Author(s):

Ildiko Lingvay ◽

Nadine Beetz ◽

Regina Sennewald ◽

Annette Schuler-Metz ◽

Julia Bertulis ◽

...

Keyword(s):

Type 2 Diabetes ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naïve Patients with Type 2 Diabetes

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-0030-1265174 ◽

2010 ◽

Vol 119 (02) ◽

pp. 63-68 ◽

Cited By ~ 18

Author(s):

N. P. E. Kadoglou ◽

A. Kapelouzou ◽

H. Tsanikidis ◽

I. Vitta ◽

C. Liapis ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Metformin Monotherapy ◽

Dose Combination ◽

Drug Naïve

Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)

Value in Health ◽

10.1016/j.jval.2016.09.1844 ◽

2016 ◽

Vol 19 (7) ◽

pp. A667

Author(s):

I Daacke ◽

S Kanters ◽

K Thorlund ◽

A Tebboth

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Relative Efficacy ◽

Efficacy And Safety ◽